Kit ELISA sandwich Plasminogen Activator (t-PA) type tissue: quantitative assay of Hu t-PA in serum or cell culture medium. The test recognizes only the natural and recombinant forms of Hu t-PA.
Kit ELISA sandwich Plasminogen Activator (t-PA) type tissue: quantitative assay of Hu t-PA in serum or cell culture medium. The test recognizes only the natural and recombinant forms of Hu t-PA.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
TPA converted the abundant but inactive proenzyme plasminogen to plasmine by hydrolysing a single Arg-Val bond in the plasminogen. By controlling plasmine-mediated proteolysis, it plays an important role in tissue remodeling and degradation, cell migration, and many other physiopathological events. It specifically cleaves the Arg--Val bond into the plasminogen to form plasmine and consists of a heterodimer of the A-chain and B-chain held by a disulfide bond. TPA binds to fibrin with high affinity. This interaction results in an increase in catalytic efficiency of the enzyme between 100 and 1000 times, due to an increase in affinity for plasminogen. Similarly, binding to heparin increases plasminogen activation. Binding to laminin and fibronectin has also been demonstrated. TPA also binds to the mannose receptor and the low density lipoprotein receptor (LRP1) protein. These proteins are involved in the clearance of TPA. TPA binds to II and cytokeratin 8. Unidentified interactions with endothelial and vascular smooth muscle cells (VSMC) result in 100-fold stimulation of plasminogen activation. In addition, binding to VSMC reduces TPA inhibition by 30 times.
Sensitivity
Sensitivity of the dosage: 6 pg/ml.
Measurement range
Dose range: 15.6 - 1.000 pg/ml.
Duration of dosing
Total duration of dosing: 2 h 10 min.
Reproducibility
Intra-dose variation coefficient 3.6%, inter-dose 6.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15154468 |
| Specifications |
| Accession number | P00750 |
| Dose range | 15.6 - 1 000 pg/ml |
| Sensitivity of the dosage | 6 pg/ml |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 5327 |
| Gene symbol(s) | T-PA,TPA |
| Coefficient of inter-dose variation | 6.5 % |
| Coefficient of intra-dose variation | 3.6% |
| Contents of kits | 96-well pre-coated plate, Stalion, Sample thinner, Dose buffer concentrate, HRP-conjugated detection antibody, Wash pad, Chromogen, Stop solution, isotypic, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Synonym | Plasminogen tissue activator |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 10 μl; supernatant, 10 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 2 h 10 min |
Origin and customs
| Manufacturer ref. | BMS258-2 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.